Industry representatives, economic development leaders and senior executives from Uniphar plc gathered at the company’s new 330,000 sq. ft. Greenogue G2 facility in Dublin last week to welcome North Carolina Governor Josh Stein during his visit to Ireland.
The Governor’s visit reflects the growing economic relationship between North Carolina and Ireland with Irish companies employing around 7,000 people across the state, while North Carolina exported nearly $890 million in goods to Ireland last year. Uniphar’s expanding investment in North Carolina includes its 65,000 sq. ft. pharmaceutical and life sciences logistics hub in Raleigh, supporting the movement of healthcare products and services throughout the United States (US) and worldwide.
Welcoming Governor Stein, Ger Rabbette, Chief Executive Officer of Uniphar plc, highlighted the strategic importance of the facility as well as the company’s growing presence in the US.
“Greenogue is one of the most sophisticated pharmaceutical distribution facilities in Europe, but it also represents a broader vision for building a more connected global healthcare infrastructure across Ireland, the UK, Europe and the United States. North Carolina was a natural choice for our US East Coast hub, providing access to one of the country’s most dynamic life sciences ecosystems and enabling us to support customers across the region. We are proud to contribute to the strong and growing economic relationship between Ireland and the United States, and particularly the partnership between Ireland and North Carolina.”
North Carolina is recognized as one of the leading life sciences centers in the United States, with a thriving pharmaceutical, biotechnology and medical technology sector. Uniphar’s 65,000 sq. ft. Raleigh distribution hub, located in North Carolina’s Research Triangle region, forms a key component of its global logistics network, connecting North American customers with the company’s wider operations across Europe, Asia-Pacific and the Middle East.
The Greenogue facility is Uniphar’s new 330,000 sq. ft. LEED Gold-certified distribution hub and one of the most advanced pharmaceutical logistics facilities in Europe. Featuring state-of-the-art automation and advanced storage and picking technologies, it forms part of Uniphar’s wider international infrastructure program to strengthen healthcare supply chains through a network of strategic distribution centers across Ireland, the UK, Europe and the United States.
From these facilities, Uniphar supports more than 200 multinational pharmaceutical and medical technology manufacturers, delivering healthcare products to over 160 countries worldwide.
Governor Stein praised both the scale of Uniphar’s investment in Ireland and the company’s commitment to North Carolina:
“Uniphar’s investment in Raleigh reflects the strong and growing partnership between North Carolina and Ireland. Its East Coast hub has further strengthened our state’s world-class life sciences sector and created new opportunities for trade and collaboration. Uniphar is one of nearly 50 Irish companies employing more than 7,000 North Carolinians, making Ireland an important part of North Carolina’s success story.”
About Uniphar plc
Uniphar plc is an international diversified healthcare services business headquartered in Dublin, Ireland, supporting more than 200 multinational pharmaceutical and medical technology manufacturers through its three divisions: Uniphar Pharma, Uniphar Medtech and Uniphar Supply Chain & Retail. The Group operates across Europe, North America, APAC and MENA and delivers to more than 160 countries worldwide.
About the Greenogue Distribution Centre
The Greenogue facility is Uniphar’s new 330,000 sq. ft. LEED Gold-standard distribution hub in South Dublin. It features state-of-the-art automation and advanced storage and picking technologies and forms part of a broader international investment program delivering new strategic distribution centers across Ireland, the UK, Europe and the United States.
Greenogue is a key component of Uniphar’s long-term growth strategy and reinforces Ireland’s position as a global hub for pharmaceutical manufacturing, healthcare innovation and supply chain excellence. The center incorporates advanced automation, market-leading warehouse management systems and real-time supply chain integration technologies to support healthcare providers and patients across Ireland and international markets.